Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
National Institute on Drug Abuse (NIDA) University of Chicago |
---|---|
Information provided by: | National Institute on Drug Abuse (NIDA) |
ClinicalTrials.gov Identifier: | NCT00000259 |
The purpose of this study is to conduct experiments to examine subjective and reinforcing effects of nitrous oxide. Mood altering and psychomotor effects will be tested on non-drug abusers and preference procedures will be used to assess reinforcing effects. Comparisons between nitrous oxide, opiates, and benzodiazepine antagonists will be made. To examine sevoflurane versus isoflurane inhalation at subanesthetic concentrations on mood, pain, and psychomotor performance.
Condition | Intervention | Phase |
---|---|---|
Opioid-Related Disorders Substance-Related Disorders |
Drug: Nitrous oxide |
Phase II |
Study Type: | Interventional |
Study Design: | Treatment |
Official Title: | Sevoflurane Vs Isoflurane Inhalation at Subanesthetic Concentrations |
Ages Eligible for Study: | 21 Years to 39 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Please contact site for information.
United States, Illinois | |
University of Chicago, Anesthesia & Critical Care | |
Chicago, Illinois, United States, 60637 |
Principal Investigator: | James Zacny, Ph.D. | University of Chicago |
Study ID Numbers: | NIDA-08391-11, R01-08391-11 |
Study First Received: | September 20, 1999 |
Last Updated: | June 23, 2005 |
ClinicalTrials.gov Identifier: | NCT00000259 |
Health Authority: | United States: Federal Government |
Mental Disorders Nitrous Oxide Isoflurane Substance-Related Disorders |
Disorders of Environmental Origin Opioid-Related Disorders Sevoflurane |
Disease Hematologic Agents Physiological Effects of Drugs Anesthetics Central Nervous System Depressants Pharmacologic Actions Anesthetics, Inhalation Pathologic Processes |
Anesthetics, General Analgesics, Non-Narcotic Sensory System Agents Therapeutic Uses Platelet Aggregation Inhibitors Peripheral Nervous System Agents Analgesics Central Nervous System Agents |